Eszopiclone is a prescription sleeping pill belonging to the class of non-benzodiazepine hypnotics. It is available as a generic medication and marketed under brand names such as Lunesta. In Hong Kong, eszopiclone is regulated by the Department of Health and is dispensed only with a doctor’s prescription. The medication is supplied as a pill in strengths of 1 mg, 2 mg, and 3 mg.
Eszopiclone exerts its sleep-inducing effect by binding selectively to the γ-aminobutyric acid type A (GABA-A) receptor complex. This binding enhances the inhibitory action of GABA, the primary neurotransmitter that calms neuronal activity. By increasing GABA-mediated chloride influx, eszopiclone reduces brain excitation, facilitating the onset of sleep.
Eszopiclone is rapidly absorbed from the gastrointestinal tract, with an oral bioavailability of approximately 80 %. It is metabolized primarily by hepatic cytochrome P450 3A4 enzymes and eliminated via the kidneys. The half-life ranges from 5 to 7 hours, supporting its use as a night-time medication.
Eszopiclone is approved by the Hong Kong Department of Health for the short-term treatment of insomnia characterized by:
The medication is generally prescribed for adults who have not responded adequately to non-pharmacologic sleep hygiene measures. Chronic insomnia or sleep disorders requiring long-term therapy should be evaluated by a specialist, as eszopiclone is intended for limited-duration use.
If any of these conditions apply, a healthcare professional should assess suitability before prescribing eszopiclone.
These effects are usually mild and resolve as the body adjusts to the medication.
Patients should disclose all prescription drugs, over-the-counter products, herbal supplements, and dietary supplements to their healthcare provider.
If specific interaction data for eszopiclone are limited, patients should always inform their healthcare provider of all concurrent substances.
Standard dosing:
Initiate therapy with 1 mg taken orally once nightly, right before bedtime.
If needed, the dose may be increased to 2 mg after 3-4 days of adequate response.
The maximum recommended dose is 3 mg per night.
Special populations:
Elderly or hepatic impairment: Start at 1 mg; avoid exceeding this dose unless closely supervised.
Administration:
Swallow the pill whole with a glass of water.
Take it on a regular schedule, preferably at the same time each night.
Do not crush or chew the tablet, as this may affect absorption.
Missed dose: If you forget to take a dose, take it as soon as you remember only if you have at least 4 hours before your planned bedtime. Otherwise, skip the missed dose and resume the regular schedule. Do not double the dose.
Overdose: Symptoms may include extreme drowsiness, respiratory depression, or coma. Seek emergency medical care immediately; supportive measures and monitoring are the mainstays of treatment.
Discontinuation: Eszopiclone does not require a taper for short-term use (≤ 2 weeks). For longer therapy, a gradual dose reduction is advisable to minimize rebound insomnia or withdrawal symptoms.
This article provides educational information about eszopiclone and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Combining eszopiclone with another hypnotic (e.g., zolpidem, benzodiazepines) increases the risk of excessive sedation, respiratory depression, and complex sleep behaviors. Such combinations should only be considered under strict medical supervision.
Yes, provided you carry the medication in its original container with a valid prescription label. Check the destination country’s regulations, as some jurisdictions may require a special permit for controlled sleep medications.
If next-day drowsiness interferes with daily activities, discuss dose reduction or alternate timing with your healthcare provider. Occasionally, taking the medication at the lowest effective dose can alleviate residual sedation.
All strengths contain the same active ingredient, eszopiclone, differing only in the amount of drug per tablet. Higher doses provide stronger sleep-promoting effects but also increase the likelihood of side effects.
Eszopiclone is intended for nighttime sleep and should be taken shortly before a main sleep period. For irregular shift schedules, timing adjustments must be individualized and discussed with a physician.
Eszopiclone tablets contain fillers such as lactose and magnesium stearate. Individuals with known allergies to these excipients should verify composition on the packaging and consult a pharmacist if concerns arise.
When used for ≤ 2 weeks, the risk of physical dependence is low. Longer durations increase the potential for tolerance and dependence, emphasizing the importance of periodic reassessment by a healthcare professional.
Eszopiclone targets the same GABA-A receptor complex but has a different chemical structure, resulting in a shorter half-life and potentially fewer next-day residual effects compared with many benzodiazepines. However, both classes share similar precautions regarding sedation and interactions.
No. Eszopiclone is a prescription-only medication in Hong Kong. Acquiring it without a valid prescription is illegal and may expose patients to counterfeit products or unsafe dosing. Always obtain the drug through a licensed pharmacy with a doctor's order.
